FIRST IN HUMAN STUDY OF AUTO4, A TRBC1‐TRAGETTING CART T CELL THERAPY IN RELAPSED/REFRACTORY TRBC1‐POSITIVE PERIPHERAL T‐CELL LYMPHOMA

Overview of attention for article published in Hematological Oncology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 1,370)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 15 X posts from 15 X users, with an upper bound of 33,494 followers.

RT @CwynKate: Delighted to present our exciting Ph1 data ‘FIRST IN HUMAN STUDY OF AUTO4, TRBC1‐TARGETING CART, IN R/R TRBC1+ve PTCL’ at #17…

RT @CwynKate: Delighted to present our exciting Ph1 data ‘FIRST IN HUMAN STUDY OF AUTO4, TRBC1‐TARGETING CART, IN R/R TRBC1+ve PTCL’ at #17…

RT @CwynKate: Delighted to present our exciting Ph1 data ‘FIRST IN HUMAN STUDY OF AUTO4, TRBC1‐TARGETING CART, IN R/R TRBC1+ve PTCL’ at #17…

RT @CwynKate: Delighted to present our exciting Ph1 data ‘FIRST IN HUMAN STUDY OF AUTO4, TRBC1‐TARGETING CART, IN R/R TRBC1+ve PTCL’ at #17…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.